6789-94-2 Usage
Description
1-Ethylpiperidin-3-amine is an organic compound that serves as a crucial intermediate in the synthesis of various pharmaceutical compounds. It is characterized by its unique molecular structure, which features a piperidine ring with an ethyl group attached to the first carbon and an amine group attached to the third carbon. 1-ETHYLPIPERIDIN-3-AMINE plays a significant role in the development of medications, particularly in the field of psychopharmacology.
Uses
Used in Pharmaceutical Industry:
1-Ethylpiperidin-3-amine is used as a key intermediate in the synthesis of 4-Amino-N-(1-ethyl-3-piperidinyl)-5-(ethylsulfonyl)-2-methoxybenzamide (A609495), which is an impurity of Amisulpride (A633250). Amisulpride is a medication used to treat schizophrenia and other psychiatric disorders. The synthesis of this intermediate is essential for the production of Amisulpride EP Impurity G, ensuring the quality and purity of the final drug product.
Check Digit Verification of cas no
The CAS Registry Mumber 6789-94-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,7,8 and 9 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 6789-94:
(6*6)+(5*7)+(4*8)+(3*9)+(2*9)+(1*4)=152
152 % 10 = 2
So 6789-94-2 is a valid CAS Registry Number.
InChI:InChI=1/C7H16N2/c1-2-9-5-3-4-7(8)6-9/h7H,2-6,8H2,1H3
6789-94-2Relevant articles and documents
INHIBITORS OF HUMAN TUMOR-EXPRESSED CCXCKR2
-
Page 87-88, (2008/06/13)
Pharmaceutical compositions containing organic compounds or salts thereof that serve as modulators for the SDF-1 or I-TAC chemokines are disclosed. The compounds and compositions are useful in the treatment of cancer, especially in the inhibition of cancer proliferation, growth, and metastasis. Methods of interfering with SDF-1 and/or I-TAC binding to the CCXCKR2 receptor and treating cancer using the compounds and pharmaceutical compositions of the present invention are also disclosed.
Separation of blood coagulation factors with non-activating polyelectrolytes
-
, (2008/06/13)
Blood coagulation factors such as Factor VIII are separated from admixture with other blood proteins without producing activation of said coagulation factors by contacting with a water-insoluble, cross-linked polyelectrolyte copolymer of (a) C2-18 unsaturated monomer and (b) C4-12 unsaturated polycarboxylic acid or anhydride which is partially substituted at its free carboxyl or anhydride sites with amine-imides and in which substantially all the remaining free carboxyl or anhydride sites are blocked with alkoxyalkylamine to form alkoxyalkylimide units.